Theme - In-depth hands-on experience on TEE Simulators
Objectives -
1. Enhance the understanding of TEE. 2. To train participants in use and interpretation of case based focused TEE 3. Promote real time management of best practices in liver transplantation 4. Utilization of VEXUS as a management tool
Focussed Group Discussion - Alcohol use disorder in liver disease
🗓️ 21 Nov 2025🕒 08:00 - 08:45📍Hall C
Theme - Focussed Group Discussion
Objectives -
Focussed Group Discussion - Alcohol use disorder in liver disease
1. Anti craving drugs: do they really work? 2. Role of Counselling for reducing heavy drinking. 3. Managing withdrawal syndrome(s) in admitted patients. 4. Role of Thiamine in patients with AUD. 5. Nutritional assessment and management .
1. To learn about shortcomings of BCLC staging and INASL modification. 2. To discuss various treatment options for early HCC. 3. To learn about role of liquid biopsy: A Non-Invasive Window into Liver Cancer.
INASL modification of BCLC staging for HCC: Refining Prognosis and Treatment Pathways
Theme - Balancing Risks and Benefits in Pediatric Metabolic Disorders
Objectives -
1. Explore the concept and rationale of preventive liver transplantation (before overt liver failure or irreversible complications) 2. Discuss disease-specific indications: Crigler–Najjar syndrome type 1 (CN1), primary hyperoxaluria, and urea cycle disorders (UCD) 3. Explore the role of specific genetic factors (e.g., DCD2 gene, NSC variants, NBAS gene) in transplant decision-making
Disease-Specific Rationale: CN1, primary hyperoxaluria, and UCD – When to consider early/preventive transplant
Theme - From Dietary Management to Transplantation Decisions
Objectives -
1. Provide an overview of liver transplantation in amino acid disorders and organic acidemias (MMA, PA, MSUD, UCD) 2. Highlight real-world experience through case discussion 3. Deciding the timing of transplant -failure of dietary management 4. Understand long-term outcomes and follow-up challenges in these patients
Indications for liver transplantation in Amino acid and Organic acid disorders; Pathophysiology and Rationale
Real-world case: Diagnostic journey, metabolic crisis management, and transplant decision
Sub Topics: 1) Management of metabolic crisis 2) When is dietary management sufficient? 3) When should liver transplantation be considered? 4) Pros, cons, and ethical dilemmas
Theme - Balancing Dietary Therapy, Growth, and Transplant Timing
Objectives -
1. Provide an overview of liver transplantation in carbohydrate metabolism disorders 2. Explore case-based dilemmas where extrahepatic involvement (e.g., cardiac disease) or growth failure drives decision-making 3. Discuss failure of dietary management and timing of liver transplantation 4. Discuss strategies for optimizing long-term outcomes after transplant
Indications for liver transplantation in disorders of carbohydrate metabolism (e.g., GSD, galactosemia, hereditary fructose intolerance)
Sub Topics: 1) Dietary Management - When is strict dietary management sufficient? when do you call "failure of dietary management" 2) Growth failure as a sole indication 3) Assessment of extrahepatic disease in transplant candidates (Renal, Muscular) 4) Oncovigilance & role of SGLT2- inhibitors
Case-Based Panel Discussion: Intermediate HCC/ advanced HCC: Immunotherapy for downstaging before Liver Transplantation
Sub topics:
1. Current criteria for considering immunotherapy for downstaging in before Liver Transplantation?
2. Patients selection- how do you select patients who are most likely to respond to immunotherapy-based downstaging? What factors (tumor burden, AFP levels, MVI status, PS ) guide your decision-making?
3. What are the major immune-related adverse events (irAEs) associated with immunotherapy in the pre-Liver Transplantation setting? Especially focus on liver injury related to immunotherapy
4. Success rates of downstaging with immunotherapy Immunotherapy impact on Post Liver Transplantation outcomes and recurrence rate
5. Is there any role of combining Immunotherapy with loco regional therapy in downstaging of HCC for Liver Transplantation 6. Role of Dual IO, Is it better than single
Theme - The Challenge of Transplant Timing and Outcomes
Objectives -
1. Provide an overview of mitochondrial hepatopathy (mitochondrial gene disorder particularly MtDNA depletion syndromes POLG, MPV 17, DGUOK etc ) and fatty acid oxidation defects as indications for liver transplantation 2. When (or whether) to transplant, given systemic involvement and uncertain benefit 3. Explore the living related donor dilemma in genetically inherited disorders 4. Understand long-term outcomes — does transplantation halt progression or shift the disease course?
Overview: Spectrum of mitochondrial hepatopathy and fatty acid oxidation defects; pathophysiology and challenges in liver transplantation
Sub Topics: 1) How do multisystem involvement & extrahepatic manifestation influence transplant candidacy 2) Optimal timing for referral & listing for liver transplantation (especially in context of evolving neurological symptoms and risk of irrversible neurodegeneration) 3) Peri Operative consideration, anaesthetic risk, postoperative complication and infection risk, unique to these patients 4) Optimal immunosupression and concern over mitotoxic agents.
Theme - The Key to key-hole surgery: The Ying and Yang of Minimal Invasive/Robotic Surgery
Objectives -
1. Understand the learning curve vis a vis technology 2. Requirements of Setting up of the minimally invasive/Robotic unit and Mentorship 3. Understanding the difference between misadventure versus retreat 4. Understand the importance and relevance of laparoscopic surgery
Robotic Donor Surgery: The learning curve and beyond
1. Define ACLF using current classifications (EASL vs APASL). 2. Explore immunologic and clinical course of ACLF patients. 3. Evaluate the role of extracorporeal therapies in improving outcomes.
Theme - From Biliary Diversion to Transplant: Evolving Treatment Paradigms
Objectives -
• Provide an overview of familial intrahepatic cholestasis (PFIC) and Alagille syndrome (ALGS), including recent advances in understanding • Explore the living related donor dilemma in PFIC and ALGS separately • Debate biliary diversion (internal vs. external) versus transplant as therapeutic strategies • Review new medical therapies (IBAT inhibitors) and their potential to shift the treatment algorithm
Overview & What’s New: Genetics, natural history, and evolving indications for intervention in PFIC and ALGS
Sub Topic 1) Mutation specific prognosis and individualized transplant timing 2) Risk of heterozygous carriers as donors - Living related donor dilemma 3) ALGS: cardiac/vascular comorbidities in recipients and donor selection 4) Role of diversion procedures in pruritus relief, progression prevention, and how they compare with Liver Transplantation
Theme - ACLF & Liver Transplantation: Who Makes the Cut?
Objectives -
1. Identify which ACLF patients benefit from liver transplantation. 2. Explore diagnostic dilemmas and management strategies in diabetic ACLF cases. 3. Engage in interactive, case-based learning on ACLF treatment pathways.
Which ACLF Needs a Liver Transplant? Identifying key clinical and prognostic markers for transplant candidacy in ACLF
10 mins ( 8 mins for presentation, 2 mins for Q&A.)
Right‑Lateralized Side‑To‑Side Cavo‑Caval Anastomosis With An Rhv‑Extended Cavotomy In Deceased‑Donor Liver Transplantation: Technique Standardisation And Early Two‑Year Outcomes From A Multi‑Centre Cohort
12:30 - 12:40
Point-Of-Care Ultrasound (Pocus) Guided Management Of Acute Kidney Injury In Patients With Cirrhosis
Dr Madhumita Premkumar
12:40 - 12:50
Efficacy Of Stereotactic Body Radiotherapy (Sbrt) In Hepatocellular Carcinoma – A Quaternary Care Centre Experience
Dr. Radhika Venugopal
12:50 - 13:00
Portal Vein Recanalization/Transcollateral Transjugular Intrahepatic Portosystemic Shunt(Tips) In Cases With Portal Cavernoma: A Short Case Series
Dr. Pratik Karak
13:00 - 13:10
Efficacy Of Synbiotics In Liver Donor Liver Transplantation Performed For Acute On Chronic Liver Failure: A Randomised Controlled Trial
Theme - Peri-Transplant management of ACLF: Challenges and Holistic Strategies
Objectives -
1. Recognize challenges of ACLF in post-transplant patients. 2. Discuss holistic strategies for alcohol-related ACLF cases. 3. Analyze transplant and non-transplant outcomes and relapse prevention.
Challenges in Managing ACLF 3 Post-Transplant: Clinical course and complications in early post-Liver Transplantation period
Theme - PPAR agonists & SGLT2 Inhibitors: A Game Changer? Educational Partner - Zydus
Objectives -
1. To analyze the role of SGLT2i role in management of diabetes in non morbidly obese patients. 2. To understand if PPARs still have any role in management of MASH?
Debate: SGLT2i are the anti-diabetic medications of choice for MASLD without morbid obesity
Comparison Of Neuromonitoring Devices In Predicting Raised Intracranial Pressure And Outcome In Acute Liver Failure Patients
Dr. Aviral Srivastava
14:30 - 14:40
Early Tracheostomy In Sick Recipients Improves Resource Utilisation And Outcomes After Liver Transplant . A Retrospective Cohort Study.
Dr. Abhishek Pandey
14:40 - 14:50
Ventilator Induced Diaphragmatic Dysfunction In Recipients And Donors Undergoing Living Donor Liver Transplantation
Dr. Sahithi Ronanki
14:50 - 15:00
Heart Of The Matter: Impact Of Pretransplant Coronary Revascularization On Post Transplant Outcomes
Dr. Susan Paulin
15:00 - 15:10
Efficacy And Safetyprofile Of Bilateral External Oblique Intercoastal Nerve Block With Cathter In Postoperative Analgesia For Hepatectomies-Case Series Of 12 Patients
Dr. Ashish Shetty
15:10 - 15:20
Point-Of-Care Ultrasound (Pocus) Guided Pragmatic Fluid And Albumin Resuscitation And Hemodynamic Monitoring In Cirrhosis And Septic Shock
Case based Panel Discussion: 50 year, diabetic male underwent Liver Transplantation for MASH related cirrhosis 2 years back, now presented with mild transaminitis and is diagnosed as recurrence of MASH
Sub-topics:
1. Prevalence of MASH- Recurrence/ De-Novo
2. Factors influencing recurrence- Pre op MASH, Metabolic risk factors, hyperlipidaemia, post op weight gain, immunosuppression
3. Strategies to prevent MASH post Liver Transplantation
4. Management – Life style/ immunosuppression/ medications
5. Role of bariatric Surgery post Liver Transplantation
Theme - Deciphering elusive portal hemodynamic and its management
Objectives -
1. Understanding the basic physiology and underlying principles. 2. Insight into the intraoperative portal flow management. 3. Scrutinizing the newer evidence.
Theme - Managing infectious aftermath of Postoperative complications
Objectives -
Identify and prioritize infectious threats in severe allograft dysfunction, balancing antimicrobial stewardship with graft salvage.
Formulate management strategies for MDR gram-negative, viral, and fungal infections with emphasis on timely diagnosis and source control Integrate diagnostics — biomarkers, molecular assays, and imaging — into individualized, evidence-based infection management in immunocompromised liver transplant recipients
Navigating infection in severe allograft dysfunction: Saving the prized possession
Theme - The Final Verdict: Understanding pathologic basis of disease(s)
Objectives -
• Case based discussion to understand real life problem • Approach to patient with post liver transplant graft dysfunction • Deciphering pathological changes in the graft and its interpretation
Continuous Suturing Technique In Hepatic Arterial Anastomosis For Liver Transplantation: Safe Technique In DDLT
Dr. Ruchir Bhavsar
17:00 - 17:06
Robotic Right Donor Hepatectomy
Dr. Siddhali Wadaskar
17:06 - 17:12
Impact Of Intraoperative Blood Product Transfusion On Outcomes Of Liver Transplantation
Dr. NEEL ISSAR
17:12 - 17:18
Portal Vein Thrombectomy In Liver Transplant: The Operative Approach
Dr. Gautham Veluru
17:18 - 17:24
Customized Reduction Of Left Lateral Segment Grafts In Pediatric Liver Transplantation: Size Fit, Not Grwr, Determines Outcome
Dr. Revanth Kalla
17:24 - 17:30
Rewriting The Outflow Rulebook: Polytetrafluoroethylene Vascular Graft For Inferior Vena Cava Thrombosis In A Case Of Live Donor Liver Transplant For Paediatric Hepatic Venous Outflow Tract Obstruction
Theme - Blending Surgical Precision with Digital Illustration.
Objectives -
Learning the implementation of Procreate app in iPad for drawing diagrams in layers for better understanding of surgical anatomy and it’s use in teaching, learning, surgical planning Etc.
Basics of using procreate app, layering, annotation Etc
Presidential Dinner - Along with a Sufi Musical Evening
🗓️ 21 Nov 2025🕒 20:00 - 23:00📍Hall A
Theme - Honoring the legacy and leadership of our past presidents
Objectives -
An evening of elegance awaits at LTSICON 2025, where a presidential dinner meets the soul-stirring rhythms of Sufi music. A night of reflection, connection, and celebration, blending fine cuisine with timeless melodies
• To understand the immunological principles of ABOi Liver Transplantation. • To explore evolving trends and long-term outcomes in ABOi Liver Transplantation. • To apply desensitization and management strategies in complex cases.
B Cell Immunology in ABO-Incompatible Liver Transplantation: Mechanisms, Monitoring, and Modulation
Theme - Clostridioides difficile infection and Gut Microbiome Dysbiosis in LT Recipients
Objectives -
1. Explain the disruption of the gut-liver axis caused by liver transplantation (LT) 2. Review the link between post-LT dysbiosis and the high risk of C. difficile infection (CDI) 3. Evaluate emerging microbiome-modulating therapies to prevent and treat post-LT complications.
The Gut-Liver Axis and its disruption: Implications it holds after Liver Transplantation
1. Review current indications and contraindications for PVR-TIPS 2. Discuss technical advances in portal vein recanalization 3. Highlight clinical outcomes, complications, and long-term follow-up 4. Present real-world case studies and multidisciplinary perspectives
From Blocked Pathways to New Lifelines: The Journey of PVR-TIPS
Case based Panel Discussion: 30 yr male with child A cirrhosis have AST and ALT of 600IU/550 IU /ml
Sub-topics: 1. What are the most likely causes of such high transaminase levels in a patient with known Child-Pugh A cirrhosis? 2. Are there any infectious or autoimmune etiologies that need to be considered and investigated further? 3. Herbal supplements, or other drugs leading to this scenario? 4. Work up for cryptogenic cirrhosis 5. Role of Liver Biopsy in this patient 6. Algorithm for work up
• To highlight unique desensitization strategies in pediatric ABOi Liver Transplantation. • To discuss management of emergency ABOi transplants. • To differentiate AMR in ABO-compatible vs. ABO-incompatible Liver Transplantation.
• Showcase cutting-edge intra-op IR techniques that redefine hepatobiliary surgery. • Explore real-time rescue strategies for vascular and biliary complications. • Discuss intra-op precision tools for safer and more effective interventions. • Highlight next-gen techniques like thrombolysis, maceration, and aneurysm control. • Inspire future-ready practice with hybrid ORs and intra-op imaging.
Scalpel Meets Catheter: The Hybrid Era of Intra-Op IR
Case based Panel Discussion: 39 yr old female diagnosed as PBC and intractable pruritus, LFTs shows ALT 880IU/ ml
Sub-topics: 1. Differentials for High ALT levels in PBC patient. 2. Diagnosis of overlap syndrome? Newer scoring system. 3. Role of AI in diagnsosis of PBC-AIH. 4. Prognosis in comparison to AIH alone. 5. Management strategy in this patient (including pruritus), Role of Liver Transplantation
Theme - Unravelling the prophylactic intricacies in Immunosuppressed
Objectives -
To understand infection risk and immune changes in liver failure and transplant settings. To review practical approaches to antimicrobial and antiviral prophylaxis in liver transplant recipients. To discuss current methods for preventing and managing CMV and other herpes viral infections.
Case based Panel Discussion: Alcoholic ACLF presenting with MELD 37 (after initial admission in local unit), proc al 2.5, blood c/s- no growth and TLC 20000/mm3, planned for an ABOi Liver Transplantation
Sub-topics:
1. How should the elevated TLC be interpreted in the context of ACLF? Is it indicative of an infection not detected by blood culture, or could it be related to the severe inflammation associated with ACLF?
2. In ALF we start prophylactic antibiotics and anti-fungal: Does same holds true for ACLF, High MELD
3. What role do other inflammatory markers (e.g., CRP, procalcitonin) play in guiding management decisions in this patient? Practice in Panelists unit
Theme - Not Just on Ice: Redefining Transplantation Through Machine Perfusion
Objectives -
1. Insight into the translational research paradigm 2. Understand various machine perfusion techniques 3. Understanding the future prospects and ethical dilemmas
Unmasking the Viable Liver: Integrating Functional Assessment and Omics Data During Machine Perfusion
Case based Panel Discussion: 52 yr female with MASH cirrhosis and recurrent hematemesis. Endoscopy shows large esophageal and gastric varices
Sub-topics: 1. What factors you will look for recurrent bleed in this patient (High HVPG/underlying PVT etc) 2. Is endoscopic management sufficient in hands of excellent endoscopist 3. Role of Dynamic contrast CT in planning further action: Discuss 4. Is it an indication for TIPS/BRTO/ EUS guided therapy/ Transplant: Discuss 5. Data on Pre-emptive TIPS: Discuss
1. Understand the spectrum of venous complications post liver transplant (hepatic vein, portal vein, IVC). 2. Highlight importance of early diagnosis with intra-op and post-op imaging. 3. Discuss surgical, endovascular and hybrid approaches.
Vascular issues in Liver Transplantation and their impact on outcomes - Setting the Stage
Theme - Scoring Systems, Prognostic Models, and Perioperative Challenges
Objectives -
1. Understand the role of scoring systems and prognostic models in timely decision-making for LT in pediatric ALF 2. Review a case journey from ALF diagnosis to LT and postoperative care 3. Decide critical issues in timing and candidate selection for transplant in ALF 4. Learn about perioperative hemodynamic monitoring and critical care in PALF 5. Discuss novel therapies and evolving strategies in PALF management
Prognostic Modeling in PALF: Diagnostic criteria and efficient use of scoring systems (e.g., King’s College, Clichy, Liver Injury Units, PALF-specific models, NWI) to guide transplant decisions
1. Insight into the evolving field of transplant oncology. 2. Provide an overview of the expanding frontiers. 3. Explore the future directions and challenges ahead.
1. Introduce the role of liver transplantation (LT) in managing hepatoblastoma 2. Review case-based learning: diagnosis, neoadjuvant therapy, LT, and postoperative chemotherapy 3. Debate primary LT vs. extreme hepatic resection in challenging cases 4. Explore current outcomes, controversies, and future directions in hepatobalstoma management
Genetics and molecular insights, risk stratification (PRETEXT), multimodality management, and when Liver Transplantation is considered
Debate: Primary Liver Transplantation vs Extreme Hepatic Resection Should borderline cases go straight to liver transplantation, or is maximal resection justified?
Debate: Primary Liver Transplantation vs Extreme Hepatic Resection Should borderline cases go straight to liver transplantation, or is maximal resection justified?
Debate: Primary Liver Transplantation vs Extreme Hepatic Resection Should borderline cases go straight to liver transplantation, or is maximal resection justified?
Rebuttal
14:56 - 15:00 Debate
Current Outcomes & Evolving Approaches: Survival, recurrence, long-term follow-up, novel agents, and future directions
Theme - AKI in cirrhosis: A spectrum, not a single snapshot
Objectives -
1. To learn about updates on AKI in cirrhosis 2. To understand management of AKI in cirrhosis with real world case discussion 3. To understand complete spectrum of Kidney dysfunction in cirrhosis
Case-Based Panel Discussion: A 45 year old decompensated cirrhotic male presented with decreased urine output. There is h/o recent ascitic tap. His serum creatinine is 2.8mg%. pretransplant management strategies
Sub Topics:
1. Discuss post ascitic tap PICD, risk factors, serum markers, prevention beyond albumin
2. Approach to AKI in this patient
3. When to start terlipressin
4. Terlipressin doesn’t work in 50% of patients with HRS- how to optimize these patients.
5. Liver Transplantation is cure for HRS- Is there any cut off of creatinine beyond which Liver Transplantation alone should not be done
Theme - From Survival to Recovery: Overcoming Malabsorption and Fueling Growth
Objectives -
1. Review the role of TPN and enteral feeding in the immediate post-transplant phase 2. Explore the causes and management of diarrhea, malabsorption, and feeding intolerance 3. Discuss strategies to induce anabolism and optimize growth post-transplant 4. Understand monitoring and adjusting nutritional interventions in the long-term
Feeding the Fragile Gut: Post transplant feeding challenges: fluid restriction, immunosuppression-induced metabolic issues, enteral vs. parenteral nutrition (immunosuppressants, infections, bile salt malabsorption, pancreatic insufficiency), diagnostic approach, and dietary interventions
Beyond Calories: Long-term growth monitoring, catch-up growth, and puberty considerations, Long-term nutrition: preventing obesity, metabolic syndrome, sarcopenia, and bone loss
Adrenocorticotropic Hormone-Stimulated Salivary Cortisol Outperforms Serum Cortisol In The Diagnosis And Prognostic Prediction Of Adrenal Insufficiency In Patients With Acute-On-Chronic Liver Failure And Decompensated Chronic Liver Disease
Dr Kevin Joy
16:30 - 16:36
Patterns In Grwr Acceptance And Their Outcomes In Adult Living Donor Liver Transplantation For Chronic Liver Disease In India- Analysis Of The Indian Liver Transplant Registry
Dr. Prasanna Gopal
16:36 - 16:42
Concurrent Intraoperative Management Of Splenic Artery Aneurysms In Adult Liver Transplant Recipients
Dr. Gagan Shetty
16:42 - 16:48
Recurrent Hepatitis A Virus Infection In The Liver Allograft Following Living Donor Transplantation: A Rare Diagnostic Challenge
Dr. Gautham Mohan
16:48 - 16:54
Dynamic Change In Liver Frailty Index Post-Hospitalization As A Prognostic Marker In Chronic Liver Disease
Dr. Visakh T
16:54 - 17:00
Randomized Trial To Compare Early Postoperative Outcomes Of Polytetrafluoroethylene Vs. Polyethylene Terephthalate Grafts In Neo-Middle Hepatic Vein Reconstruction For Right Lobe Living Donor Liver Transplantation(Ctri Registration- 2025/06/108534)
Dr Venkat Karlapudi
17:00 - 17:06
Long Term Impact Of The Perioperative Kidney Function Dynamics In Liver Transplant: Is There A Method In Madness?
Dr. Niteen Kumar
17:06 - 17:12
Clinicopathological Profile And Outcomes Of Severe Hepatitis A Outbreak In India: A Multicenter Cross-Sectional Study
Dr. Gowripriya Nair
17:12 - 17:18
Post-Operative Allograft Function Following Living Donor Liver Transplantation With Monophasic Versus Bi / Triphasic Hepatic Venous Outflows: An Ambispective Observational Study
Dr. Aniket Mishra
17:18 - 17:24
Comparative Analysis Of Albi And Crafity Scores As Predictors Of Immunotherapy Response In Hcc
Theme - The Big 'small' Challenge: From hepatectomy to reductions and from inflow to outflow
Objectives -
1. Explore the challenges of Paediatric recipient hepatectomy and size matching. 2. Explore the outflow challenges and technique. 3. Understanding the inflow techniques. 4. Understand the Diagnosis and management of postoperative complications.
Optimizing preoperative period: Management of small babies and how to grow them pretransplant
Theme - Obese MASLD: Are newer anti-obesity medications good enough? Educational Partner- Novo Nordisk
Objectives -
1. To learn about newer medical anti-obesity strategies. 2. To learn about pre op optimization of obese cirrhotic with real world case. 3. To learn about strategies to reduce weight in cirrhosis before surgery.
Crossroads of Care - The intersection of Obesity and Liver Disease
Case-Based Panel Discussion: 45 yr Female with Decompensated CLD (CTP B7) with BMI 33 planned for right hemicolectomy for Carcinoma Colon. Pre op optimization strategy.
Sub Topics:
1. What are Challenges in this patient?
2. Cardiopulmonary assessment and optimization
3. Optimization of cirrhosis (Albumin infusion? TEG analysis, protein intake, variceal evaluation/ evaluation of portal hypertension/ collaterals)
4. Does pre op weight reduction in this patient will improves outcome/ strategies
Practice suturing using intact latex glove Participants will develop precision hand movements and needle control on a latex glove, simulating delicate tissue handling. This exercise helps reinforce fine motor coordination and basic suturing technique in a controlled setting.
11:00 - 12:00 Hands on
Practice suturing using Silicone micro vessels Simulated micro vessels made of silicone allow participants to practice vascular anastomosis and fine suturing under magnification. It mimics real-life vessel suturing challenges in liver transplant surgery.
12:00 - 13:00 Hands on
Practice suturing on chicken wing vein tissue model
This realistic tissue model provides tactile feedback and simulates human vein texture, enhancing practical surgical skills.
13:00 - 14:00 Hands on
Batch 2
Practice suturing using intact latex glove Participants will develop precision hand movements and needle control on a latex glove, simulating delicate tissue handling. This exercise helps reinforce fine motor coordination and basic suturing technique in a controlled setting.
14:00 - 15:00
Batch 2
Practice suturing using Silicone micro vessels Simulated micro vessels made of silicone allow participants to practice vascular anastomosis and fine suturing under magnification. It mimics real-life vessel suturing challenges in liver transplant surgery.
15:00 - 16:00 Hands on Workshop
Batch 2
Practice suturing on chicken wing vein tissue model This realistic tissue model provides tactile feedback and simulates human vein texture, enhancing practical surgical skills.
Case-based Panel Discussion: 55 yr old lady with HBV related HCC with post Liver transplant recurrence of HCC: Management
Sub Topics: 1. Tumor recurrence- Risk factors a) Tumor related b) Patient related c) Treatment related 2. Post Liver Transplantation surveillance – (Retreat score, interval of imaging/biomarkers testing) 3. Immunosuppression decision in HCC patients 4. Treatment (Curative/ palliative)- Discuss Surgical resection and loco regional therapies 5. Immunotherapy post Liver transplant- Any role?
1. Review tools to assess sarcopenia and frailty in cirrhosis and their role in transplant evaluation. 2. Understand how sarcopenia and refractory ascites influence liver transplant outcomes. 3. Explore prehabilitation strategies to improve post-transplant recovery and survival.
Integrating ascites and sarcopenia in transplant decision-making: Role of assessment tools
Pre Liver Transplantation rehabilitation: Prehabilitation approach in Liver Transplant recipients and its impact on Post Liver Transplantation outcomes
Case: “Refractory Ascites in Cirrhosis: Managing Beyond Diuretics” Sub-topics: 1) Pathophysiology and modern management strategies (TIPS, albumin infusions, vasoconstrictors). 2) When to bridge to transplant and when to delist. 3) Impact of refractory ascites on perioperative mortality.
Theme - Navigate ALF with Precision: Etiological Patterns, ICU Care, Dynamic Scores, and Transplant Readiness
Objectives -
1. Discuss recent changes in etiological pattern of ALF. 2. Discuss natural history of DILI related ALF and need for early transplant. 3. Analyze need and advantages of dynamic scoring over KCC for transplant in ALF. 4. To learn about dynamics and outcomes of hyperacute ALF 5. Managing ALF intraop during LT surgical and anaesthetic perspectives"
Case-Based Panel Discussion: 27 F with HAV related hyperacute ALF admitted in liver ICU: care/monitoring/ALSS/Tx Listing
Sub topics 1. ALF in emergency department- Things to do 2. ICU care of ALF patient (when to MV, ICP monitoring, Nutrition, Antibiotics/ antifungals of choice) 3. Artificial liver support system (Plasma exchange/CRRT)- Patient selection, prevention of infections, CRRT first or plasma exchange- how to decide) 4. Does Dynamic scores help in deciding for Liver Transplant listing
Case based Panel Discussion: 45 y old lady with child B cirrhosis, detected to have partial PV thrombosis on screening USG
Sub-topics: 1. Further assessment- CT triple phase role, Procoagulant workup. Variceal screening (before anti coagulants) 2. Indication for anti-coagulants? 3. In case of < 30% luminal compromise how will you monitor this patient? 4. Challenges in Liver Transplantation in this patient
Theme - Navigating the Metabolic Maze: MASLD and Liver Transplant Outcomes
Objectives -
1. To understand how Metabolic mayhem fuels the MASLD fire 2. To gain insights in optimizing MASLD donor 3. To understand pre op assessment & optimization of morbidly obese cirrhotic undergoing Liver Transplantation with case based panel discussion
Case based Panel Discussion: 58 yr old morbidly obese cirrhotic (MELD 20) planned for Liver Transplantation. Risk assessment and optimizing for Liver Transplantation
Sub-topics:
1. Morbid obesity and potential donor-recipient mismatch, in living donor LT (LDLT)?
2. What are the potential perioperative and post-transplant complications associated with obesity in this specific case?
3. Does the presence of sarcopenia (muscle wasting), along with obesity (sarcopenic obesity), further impact prognosis and potential post-LT complications?
4. What are the most appropriate and effective weight loss strategies for this patient, considering the liver function and potential risks of worsening malnutrition or sarcopenia? Does GLP1 agonist have any role?
5. If considering bariatric surgery, what are the optimal timing (before, during, or after LT) and the most appropriate surgical approach (e.g., sleeve gastrectomy), weighing the benefits and risks in this specific clinical context?
